This study focuses on improving how primary care teams identify patients who smoke and offer access to nicotine replacement therapy, or NRT. NRT includes medications such as nicotine patches, gum, or lozenges that can reduce cravings and support people who are interested in cutting back or quitting smoking. Although NRT is an evidence-based treatment option, it is not always discussed or prescribed during routine primary care visits. To better understand how NRT can be offered in primary care, the project will test a workflow at Penn Family Care that identifies patients who currently smoke and provides information about available tobacco treatment options. Edward Cooper Internal Medicine will serve as a comparison site. Patients who smoke and/or are prescribed NRT will also receive a 30-day follow-up survey to learn whether they received, picked up, or used NRT; whether it was useful; and what barriers they experienced.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
4,800
Participants who are in the intervention arm will receive tobacco counseling resources via the Way to Health platform. Way to Health will send text message links to tobacco cessation counseling resources (PA Quitline and/or SmokeFreeTXT).
Proportion of Active Smokers with a Signed NRT Prescription
The primary outcome will be proportion of patients with a signed NRT prescription (signed between 3 days prior to scheduled visit and 30 days after completed visit) among those documented as active smokers in the EHR as of this visit who did not have an NRT prescription in the 34 to 4 days prior. A sensitivity analysis will include additional patients identified as smokers through pre-visit surveys.
Time frame: From 3 days before scheduled visit and 30 days after completed visit.
Sensitivity of EHR Active Smoker Designation
Sensitivity of EHR active smoker designation using tobacco questionnaire response as benchmark (Treatment-site Secondary Outcome Measure 1)
Time frame: At completion of pre-visit tobacco questionnaire (baseline)
Specificity of EHR Active Smoker Designation
Specificity of EHR active smoker designation using tobacco questionnaire response as benchmark (Treatment-site Secondary Outcome Measure 2)
Time frame: At completion of pre-visit tobacco questionnaire (baseline)
Accuracy of EHR Active Smoker Designation
Accuracy of EHR active smoker designation using tobacco questionnaire response as benchmark (Treatment-site Secondary Outcome Measure 3)
Time frame: At completion of pre-visit tobacco questionnaire (baseline)
Proportion of Tobacco Questionnaire-Identified Smokers Selecting Each Benefit of Quitting
Proportion of tobacco questionnaire-identified smokers who select each benefit of quitting (Treatment-site Secondary Outcome Measure 4)
Time frame: At completion of the pre-visit tobacco questionnaire (baseline)
Proportion of Tobacco Questionnaire-Identified Smokers Selecting Each of the Three Treatments
Proportion who select each of the three treatments (Treatment-site Secondary Outcome Measure 5)
Time frame: At completion of the pre-visit tobacco questionnaire (baseline)
Proportion of Participants Selecting NRT Whose Clinician Signs the Pended Order
Proportion selecting NRT whose clinician signs the pended order (Treatment-site Secondary Outcome Measure 6)
Time frame: From completion of the pre-visit tobacco questionnaire through 30-days after the completed visit
Proportion of Participants With Any NRT Prescription Recorded in the EHR
Any NRT prescription in the EHR during the study period (Both-sites Secondary Outcome Measure 7)
Time frame: From study start for first participant to 6 months later
Proportion of Participants Reporting NRT Use at 30-Day Follow-Up
30-day self-reported NRT use (Both-sites Secondary Outcome Measure 8)
Time frame: 30 days after completed visit, at time of follow-up survey completion
Proportion of Participants Reporting Engagement With Tobacco Cessation Counseling Resources at 30-Day Follow-Up
30-day self-reported engagement with tobacco cessation counseling resources (Both-sites Secondary Outcome Measure 9)
Time frame: 30 days after completed visit, at time of follow-up survey completion
Proportion of Participants Reporting Each Smoking Status at 30-Day Follow-Up
30-day self-reported smoking status (Both-sites Secondary Outcome Measure 10)
Time frame: 30 days after completed visit, at time of follow-up survey completion
Proportion of Participants Reporting Changes in Smoking Behavior at 30-Day Follow-Up
30-day self-reported changes in smoking behavior (Both-sites Secondary Outcome Measure 11)
Time frame: 30 days after completed visit, at time of follow-up survey completion
Proportion of Participants With a New or Refill NRT Prescription Recorded in the EHR
New/refill NRT prescription in EHR 30-60 days after completed visit (Both-sites Secondary Outcome Measure 12)
Time frame: 30 to 60 days after the completed visit
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.